The following is a summary of “Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1,” published in the May 2025 issue of Journal ...

Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...

Background: Major noncardiac surgery carries high rates of postoperative myocardial injury and other complications. Remote ischemic preconditioning (RIPC) was reported to decrease these complications.

SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there ...

Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. has divulged compounds acting as apolipoprotein A (ApoA; LPA) inhibitors reported to be useful for the treatment of hyperlipidemia, ...

A heart attack, also known as myocardial infarction, occurs when blood flow to a portion of the heart suddenly gets blocked, ...

Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the ...

Patients with AAV are associated with an increased risk for MI, particularly during the first 3 months after diagnosis.

Prophylactic use of nonsteroidal anti-inflammatory drugs posed higher cardiovascular risk than colchicine or no prophylaxis ...

The following is a summary of “Prognostic Implications Of High-Sensitivity Cardiac Troponins In Patients With Acute Kidney ...

A paper published by professors Kim Min-cheol and Ahn Young-geun of the Department of Circulatory Mechanism at Chonnam ...

The global populating is aging, and approximately 29% of people with diabetes worldwide are aged 65 years and older, representing 123 million people, according to a speaker at the Heart in Diabetes ...